Home/Pipeline/GSK3640254

GSK3640254

Pulmonary Arterial Hypertension

Phase 2Active

Key Facts

Indication
Pulmonary Arterial Hypertension
Phase
Phase 2
Status
Active
Company

About GSK plc

GSK plc is one of the world's leading pharmaceutical companies, headquartered in London, with operations in over 100 countries. The company has transformed from a traditional pharmaceutical giant into a focused biopharma company through strategic divestitures and increased R&D investment. GSK maintains leadership positions in respiratory diseases, HIV treatment, vaccines, and has a growing oncology portfolio. The company is publicly traded on the London Stock Exchange and NYSE with a market capitalization exceeding $100 billion.

View full company profile

Other Pulmonary Arterial Hypertension Drugs

DrugCompanyPhase
PAH ProgramInsmedPhase 2b
Treprostinil (Remodulin)United TherapeuticsCommercial
Treprostinil (Orenitram)United TherapeuticsCommercial
Selexipag (Uptravi)United TherapeuticsCommercial
RalinepagUnited TherapeuticsPhase 3
Orenitram®Supernus PharmaceuticalsApproved/Commercial
Tadliq® (Tadalafil Oral Suspension)CMP PharmaApproved